Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 15 | 2017 | 664 | 1.690 |
Why?
|
Mississippi | 24 | 2017 | 122 | 0.930 |
Why?
|
Middle Aged | 55 | 2024 | 10129 | 0.820 |
Why?
|
Pharmacists | 2 | 2021 | 53 | 0.760 |
Why?
|
Blood Pressure | 10 | 2021 | 646 | 0.760 |
Why?
|
Aged | 46 | 2024 | 6741 | 0.760 |
Why?
|
Public Health Administration | 1 | 2020 | 26 | 0.750 |
Why?
|
Workload | 1 | 2020 | 22 | 0.710 |
Why?
|
Pharmacy | 1 | 2020 | 30 | 0.700 |
Why?
|
Adult | 47 | 2021 | 11712 | 0.670 |
Why?
|
Obesity | 7 | 2020 | 1067 | 0.670 |
Why?
|
Students, Pharmacy | 1 | 2020 | 47 | 0.660 |
Why?
|
Hypertension | 8 | 2021 | 796 | 0.650 |
Why?
|
Humans | 75 | 2024 | 37093 | 0.650 |
Why?
|
Female | 58 | 2024 | 20969 | 0.620 |
Why?
|
Tobacco Use Cessation | 1 | 2017 | 16 | 0.600 |
Why?
|
Male | 56 | 2024 | 20025 | 0.590 |
Why?
|
Aged, 80 and over | 25 | 2021 | 2379 | 0.570 |
Why?
|
Cholesterol, HDL | 4 | 2014 | 97 | 0.570 |
Why?
|
Risk Factors | 23 | 2017 | 3562 | 0.560 |
Why?
|
Young Adult | 22 | 2021 | 4268 | 0.550 |
Why?
|
Social Class | 6 | 2013 | 247 | 0.530 |
Why?
|
Cohort Studies | 17 | 2024 | 1492 | 0.520 |
Why?
|
Biomedical Research | 4 | 2024 | 400 | 0.520 |
Why?
|
Christianity | 1 | 2015 | 7 | 0.510 |
Why?
|
Triglycerides | 4 | 2014 | 138 | 0.490 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2017 | 864 | 0.480 |
Why?
|
Diabetes Mellitus | 5 | 2015 | 485 | 0.450 |
Why?
|
Insulin Resistance | 4 | 2012 | 184 | 0.450 |
Why?
|
United States | 11 | 2022 | 4223 | 0.440 |
Why?
|
Prevalence | 12 | 2017 | 1455 | 0.440 |
Why?
|
Body Mass Index | 10 | 2018 | 854 | 0.410 |
Why?
|
Lung | 2 | 2014 | 446 | 0.410 |
Why?
|
Coronary Artery Bypass | 3 | 2017 | 43 | 0.400 |
Why?
|
Students | 1 | 2017 | 519 | 0.400 |
Why?
|
Hormone Replacement Therapy | 1 | 2011 | 41 | 0.390 |
Why?
|
Weight Loss | 2 | 2023 | 131 | 0.390 |
Why?
|
Menopause | 1 | 2011 | 56 | 0.390 |
Why?
|
Glucose Intolerance | 1 | 2011 | 42 | 0.390 |
Why?
|
Magnesium | 2 | 2021 | 97 | 0.380 |
Why?
|
Quality of Life | 2 | 2018 | 481 | 0.370 |
Why?
|
Coronary Disease | 1 | 2010 | 124 | 0.340 |
Why?
|
Multivariate Analysis | 7 | 2020 | 583 | 0.340 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2015 | 45 | 0.330 |
Why?
|
Life Style | 2 | 2023 | 308 | 0.330 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 2721 | 0.320 |
Why?
|
Health Promotion | 1 | 2015 | 653 | 0.320 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 142 | 0.320 |
Why?
|
Environment | 1 | 2009 | 138 | 0.320 |
Why?
|
Louisiana | 4 | 2023 | 43 | 0.300 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2009 | 215 | 0.290 |
Why?
|
Blood Glucose | 4 | 2014 | 353 | 0.280 |
Why?
|
Prospective Studies | 10 | 2017 | 1378 | 0.270 |
Why?
|
Cardiotonic Agents | 2 | 2017 | 37 | 0.270 |
Why?
|
Sleep | 3 | 2021 | 152 | 0.270 |
Why?
|
Atrial Fibrillation | 2 | 2017 | 101 | 0.250 |
Why?
|
Stress, Psychological | 4 | 2016 | 583 | 0.250 |
Why?
|
Retrospective Studies | 8 | 2021 | 2026 | 0.250 |
Why?
|
Health Status Disparities | 5 | 2019 | 642 | 0.240 |
Why?
|
Secondary Prevention | 1 | 2024 | 38 | 0.240 |
Why?
|
Regression Analysis | 4 | 2020 | 455 | 0.240 |
Why?
|
Recurrence | 1 | 2024 | 131 | 0.240 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 4 | 2017 | 63 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2021 | 643 | 0.230 |
Why?
|
Echocardiography | 4 | 2015 | 144 | 0.230 |
Why?
|
Exercise | 3 | 2020 | 613 | 0.220 |
Why?
|
Hospitalization | 2 | 2011 | 388 | 0.220 |
Why?
|
Minority Health | 2 | 2022 | 88 | 0.210 |
Why?
|
Adolescent | 8 | 2021 | 5363 | 0.200 |
Why?
|
Population Surveillance | 4 | 2014 | 238 | 0.200 |
Why?
|
Research Design | 4 | 2018 | 313 | 0.200 |
Why?
|
Program Development | 2 | 2015 | 233 | 0.190 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 21 | 0.190 |
Why?
|
Intra-Abdominal Fat | 2 | 2012 | 45 | 0.190 |
Why?
|
Stroke | 1 | 2024 | 286 | 0.190 |
Why?
|
Breast Neoplasms | 1 | 2011 | 1502 | 0.180 |
Why?
|
Genetic Loci | 2 | 2010 | 90 | 0.180 |
Why?
|
Insulin | 2 | 2012 | 236 | 0.180 |
Why?
|
Longitudinal Studies | 8 | 2012 | 885 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2014 | 169 | 0.170 |
Why?
|
Vulnerable Populations | 1 | 2020 | 140 | 0.170 |
Why?
|
Primary Health Care | 2 | 2020 | 294 | 0.160 |
Why?
|
Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
Calcium | 1 | 2021 | 480 | 0.160 |
Why?
|
C-Reactive Protein | 2 | 2010 | 149 | 0.160 |
Why?
|
Prenatal Diagnosis | 1 | 2018 | 12 | 0.160 |
Why?
|
Urban Population | 2 | 2010 | 333 | 0.160 |
Why?
|
Minority Groups | 2 | 2022 | 596 | 0.150 |
Why?
|
Patient Education as Topic | 2 | 2020 | 215 | 0.150 |
Why?
|
Prenatal Care | 1 | 2018 | 73 | 0.150 |
Why?
|
Incidence | 4 | 2015 | 922 | 0.150 |
Why?
|
Circadian Rhythm | 3 | 2016 | 225 | 0.140 |
Why?
|
Diastole | 2 | 2021 | 42 | 0.140 |
Why?
|
Sex Factors | 4 | 2012 | 898 | 0.140 |
Why?
|
Universities | 2 | 2017 | 442 | 0.140 |
Why?
|
Obesity, Abdominal | 2 | 2014 | 30 | 0.130 |
Why?
|
Rural Population | 3 | 2018 | 294 | 0.130 |
Why?
|
Cholesterol | 1 | 2017 | 205 | 0.130 |
Why?
|
Postoperative Care | 1 | 2015 | 18 | 0.130 |
Why?
|
Postoperative Complications | 1 | 2017 | 210 | 0.130 |
Why?
|
Risk | 4 | 2018 | 267 | 0.130 |
Why?
|
Healthcare Disparities | 1 | 2020 | 494 | 0.130 |
Why?
|
Organizational Objectives | 1 | 2015 | 28 | 0.130 |
Why?
|
Nicotine | 1 | 2017 | 257 | 0.120 |
Why?
|
Prognosis | 3 | 2015 | 739 | 0.120 |
Why?
|
Insecticide-Treated Bednets | 1 | 2014 | 8 | 0.120 |
Why?
|
Infant Care | 1 | 2014 | 4 | 0.120 |
Why?
|
Telemedicine | 1 | 2018 | 182 | 0.120 |
Why?
|
Personnel, Hospital | 1 | 2014 | 10 | 0.120 |
Why?
|
Health Surveys | 3 | 2014 | 373 | 0.120 |
Why?
|
Mosquito Control | 1 | 2014 | 14 | 0.120 |
Why?
|
Infant, Newborn, Diseases | 1 | 2014 | 21 | 0.120 |
Why?
|
Electrocardiography | 2 | 2013 | 156 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 45 | 0.120 |
Why?
|
Hypokalemia | 1 | 2013 | 11 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2021 | 1130 | 0.120 |
Why?
|
Heart Conduction System | 1 | 2013 | 14 | 0.120 |
Why?
|
Infant Mortality | 1 | 2014 | 55 | 0.110 |
Why?
|
Quality Assurance, Health Care | 1 | 2014 | 56 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2013 | 21 | 0.110 |
Why?
|
Proteinuria | 1 | 2013 | 50 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2010 | 188 | 0.110 |
Why?
|
Malaria | 1 | 2014 | 78 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2011 | 85 | 0.110 |
Why?
|
Parenting | 1 | 2013 | 127 | 0.110 |
Why?
|
Allostasis | 1 | 2012 | 12 | 0.110 |
Why?
|
Refusal to Participate | 1 | 2012 | 3 | 0.100 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.100 |
Why?
|
Persuasive Communication | 1 | 2011 | 8 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2012 | 55 | 0.100 |
Why?
|
Public Health Practice | 1 | 2011 | 40 | 0.100 |
Why?
|
Spirometry | 1 | 2011 | 33 | 0.100 |
Why?
|
Income | 1 | 2012 | 140 | 0.100 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 68 | 0.100 |
Why?
|
Disease Progression | 2 | 2015 | 601 | 0.100 |
Why?
|
Age Factors | 2 | 2012 | 1033 | 0.100 |
Why?
|
Motivation | 1 | 2015 | 436 | 0.100 |
Why?
|
Adiponectin | 1 | 2011 | 55 | 0.100 |
Why?
|
Prejudice | 1 | 2012 | 110 | 0.100 |
Why?
|
Models, Biological | 1 | 2014 | 677 | 0.090 |
Why?
|
Sodium Channels | 1 | 2011 | 67 | 0.090 |
Why?
|
Educational Status | 1 | 2012 | 313 | 0.090 |
Why?
|
Health Education | 1 | 2013 | 338 | 0.090 |
Why?
|
Pericardium | 1 | 2010 | 15 | 0.090 |
Why?
|
Health Status Indicators | 2 | 2007 | 75 | 0.090 |
Why?
|
Ghana | 3 | 2014 | 32 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 49 | 0.090 |
Why?
|
Research Personnel | 2 | 2022 | 155 | 0.090 |
Why?
|
Patient Compliance | 1 | 2011 | 212 | 0.090 |
Why?
|
Geographic Information Systems | 1 | 2010 | 39 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2009 | 13 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 37 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2010 | 119 | 0.090 |
Why?
|
Public Policy | 1 | 2009 | 32 | 0.080 |
Why?
|
Professional Competence | 1 | 2009 | 40 | 0.080 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 385 | 0.080 |
Why?
|
Health Services | 1 | 2009 | 57 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 96 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 68 | 0.080 |
Why?
|
Dyslipidemias | 1 | 2009 | 43 | 0.080 |
Why?
|
Phenotype | 2 | 2009 | 689 | 0.080 |
Why?
|
Lipids | 1 | 2010 | 235 | 0.080 |
Why?
|
Workplace | 1 | 2009 | 87 | 0.080 |
Why?
|
Needs Assessment | 1 | 2010 | 170 | 0.080 |
Why?
|
Attitude | 1 | 2009 | 104 | 0.080 |
Why?
|
Genome, Human | 1 | 2009 | 135 | 0.080 |
Why?
|
Residence Characteristics | 3 | 2005 | 322 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2013 | 628 | 0.070 |
Why?
|
Schools | 1 | 2009 | 260 | 0.070 |
Why?
|
Proteins | 1 | 2010 | 369 | 0.070 |
Why?
|
Health Literacy | 2 | 2020 | 105 | 0.070 |
Why?
|
Smoking | 1 | 2014 | 940 | 0.070 |
Why?
|
Health Behavior | 1 | 2011 | 537 | 0.070 |
Why?
|
Systole | 2 | 2021 | 61 | 0.070 |
Why?
|
Linkage Disequilibrium | 3 | 2012 | 85 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2012 | 767 | 0.070 |
Why?
|
Waist Circumference | 3 | 2012 | 89 | 0.070 |
Why?
|
Laboratories | 1 | 2004 | 35 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 2004 | 36 | 0.060 |
Why?
|
Cardiology | 1 | 2024 | 17 | 0.060 |
Why?
|
Logistic Models | 3 | 2013 | 923 | 0.060 |
Why?
|
History, 21st Century | 1 | 2024 | 81 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2024 | 61 | 0.060 |
Why?
|
History, 20th Century | 1 | 2024 | 117 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2010 | 333 | 0.060 |
Why?
|
Feedback | 1 | 2023 | 53 | 0.060 |
Why?
|
Patient Selection | 1 | 2005 | 164 | 0.060 |
Why?
|
Disabled Persons | 1 | 2024 | 65 | 0.060 |
Why?
|
Research | 1 | 2004 | 163 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 1067 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 88 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2014 | 894 | 0.050 |
Why?
|
Pregnancy | 3 | 2018 | 1549 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2012 | 149 | 0.050 |
Why?
|
Focus Groups | 1 | 2023 | 348 | 0.050 |
Why?
|
Actigraphy | 1 | 2021 | 15 | 0.050 |
Why?
|
Sex Distribution | 2 | 2013 | 215 | 0.050 |
Why?
|
Qualitative Research | 1 | 2023 | 446 | 0.050 |
Why?
|
Diet, Reducing | 1 | 2020 | 24 | 0.050 |
Why?
|
Hospitals | 1 | 2021 | 86 | 0.050 |
Why?
|
Time Factors | 2 | 2015 | 1742 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 160 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2019 | 80 | 0.040 |
Why?
|
Computers, Handheld | 1 | 2018 | 6 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 14 | 0.040 |
Why?
|
Nigeria | 1 | 2018 | 86 | 0.040 |
Why?
|
Linear Models | 2 | 2009 | 275 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2019 | 169 | 0.040 |
Why?
|
Rural Health Services | 1 | 2018 | 44 | 0.040 |
Why?
|
Perioperative Care | 1 | 2017 | 6 | 0.040 |
Why?
|
Genotype | 2 | 2011 | 730 | 0.040 |
Why?
|
Patient Participation | 1 | 2018 | 75 | 0.040 |
Why?
|
Interviews as Topic | 2 | 2011 | 381 | 0.040 |
Why?
|
Cultural Competency | 1 | 2018 | 131 | 0.040 |
Why?
|
Self Care | 1 | 2018 | 159 | 0.030 |
Why?
|
Internet | 1 | 2018 | 211 | 0.030 |
Why?
|
Comorbidity | 2 | 2011 | 623 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2016 | 59 | 0.030 |
Why?
|
Child | 2 | 2014 | 3131 | 0.030 |
Why?
|
Forecasting | 1 | 2016 | 128 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2018 | 276 | 0.030 |
Why?
|
Poverty | 1 | 2018 | 348 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2016 | 217 | 0.030 |
Why?
|
Hospitals, District | 1 | 2014 | 2 | 0.030 |
Why?
|
World Health Organization | 1 | 2014 | 31 | 0.030 |
Why?
|
Delphi Technique | 1 | 2013 | 23 | 0.030 |
Why?
|
Maryland | 1 | 2014 | 53 | 0.030 |
Why?
|
International Cooperation | 1 | 2014 | 46 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 55 | 0.030 |
Why?
|
Inservice Training | 1 | 2014 | 33 | 0.030 |
Why?
|
Insecticides | 1 | 2014 | 51 | 0.030 |
Why?
|
Psychological Theory | 1 | 2013 | 24 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 144 | 0.030 |
Why?
|
Cause of Death | 1 | 2014 | 156 | 0.030 |
Why?
|
Lung Diseases | 1 | 2014 | 61 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 753 | 0.030 |
Why?
|
Social Support | 1 | 2016 | 394 | 0.030 |
Why?
|
Child Development | 1 | 2013 | 88 | 0.030 |
Why?
|
Mentors | 1 | 2014 | 127 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2016 | 935 | 0.030 |
Why?
|
Alleles | 1 | 2013 | 321 | 0.030 |
Why?
|
Program Evaluation | 1 | 2014 | 339 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 77 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2012 | 93 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2015 | 974 | 0.030 |
Why?
|
Gene Frequency | 1 | 2012 | 195 | 0.030 |
Why?
|
Radiography | 1 | 2012 | 72 | 0.030 |
Why?
|
Curriculum | 1 | 2013 | 265 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2011 | 38 | 0.020 |
Why?
|
Overweight | 1 | 2014 | 247 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 52 | 0.020 |
Why?
|
Osteopetrosis | 1 | 1991 | 2 | 0.020 |
Why?
|
Pilot Projects | 1 | 2013 | 661 | 0.020 |
Why?
|
Awareness | 1 | 2011 | 65 | 0.020 |
Why?
|
Tibia | 1 | 1991 | 18 | 0.020 |
Why?
|
Body Composition | 1 | 2012 | 162 | 0.020 |
Why?
|
Fasting | 1 | 2011 | 54 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 36 | 0.020 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 4 | 0.020 |
Why?
|
Pregnancy, Multiple | 1 | 1990 | 6 | 0.020 |
Why?
|
Trust | 1 | 2012 | 133 | 0.020 |
Why?
|
Infant | 1 | 2014 | 1046 | 0.020 |
Why?
|
Twins | 1 | 1990 | 17 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 534 | 0.020 |
Why?
|
Aortic Diseases | 1 | 2010 | 27 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 29 | 0.020 |
Why?
|
Censuses | 1 | 2010 | 24 | 0.020 |
Why?
|
Fetal Blood | 1 | 1990 | 50 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1990 | 77 | 0.020 |
Why?
|
Genetics, Population | 1 | 2010 | 100 | 0.020 |
Why?
|
Calcinosis | 1 | 2010 | 59 | 0.020 |
Why?
|
Heart Rate | 1 | 2011 | 253 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 1418 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2009 | 21 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 139 | 0.020 |
Why?
|
Albuminuria | 1 | 2010 | 76 | 0.020 |
Why?
|
Demography | 1 | 2010 | 175 | 0.020 |
Why?
|
Markov Chains | 1 | 2009 | 35 | 0.020 |
Why?
|
Oxygen | 1 | 1990 | 207 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 214 | 0.020 |
Why?
|
Health Status | 1 | 2012 | 380 | 0.020 |
Why?
|
Myocardium | 1 | 2011 | 235 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2008 | 15 | 0.020 |
Why?
|
Databases, Factual | 1 | 2010 | 291 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2010 | 134 | 0.020 |
Why?
|
Software | 1 | 2010 | 217 | 0.020 |
Why?
|
Genetic Variation | 1 | 2009 | 387 | 0.020 |
Why?
|
Heart Failure | 1 | 2009 | 235 | 0.020 |
Why?
|
Psychometrics | 1 | 2007 | 318 | 0.020 |
Why?
|
Depression | 1 | 2012 | 712 | 0.020 |
Why?
|
Research Subjects | 1 | 2005 | 32 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 2303 | 0.010 |
Why?
|
Bone Resorption | 1 | 1991 | 8 | 0.010 |
Why?
|
Osteoclasts | 1 | 1991 | 14 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1991 | 80 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1991 | 142 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1991 | 209 | 0.010 |
Why?
|
Apgar Score | 1 | 1990 | 5 | 0.010 |
Why?
|
Labor Presentation | 1 | 1990 | 2 | 0.010 |
Why?
|
Bicarbonates | 1 | 1990 | 13 | 0.010 |
Why?
|
Cesarean Section | 1 | 1990 | 55 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 550 | 0.010 |
Why?
|
Mice | 1 | 1991 | 5913 | 0.000 |
Why?
|
Animals | 1 | 1991 | 15081 | 0.000 |
Why?
|